NHI — National Health Investors Share Price
0.000.00%
Last trade - 00:00- $3.51bn
- $4.65bn
- $335.18m
- 74
- 37
- 86
- 72
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 23.79 | ||
| PEG Ratio (f) | 12.19 | ||
| EPS Growth (f) | 1.99% | ||
| Dividend Yield (f) | 4.89% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.57 | ||
| Price to Tang. Book | 2.57 | ||
| Price to Free Cashflow | 53.52 | ||
| Price to Sales | 10.47 | ||
| EV to EBITDA | 18.26 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.72% | ||
| Return on Equity | 10.52% | ||
| Operating Margin | 36.79% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 332.81 | 298.71 | 278.19 | 319.83 | 335.18 | 354.74 | 396.47 | 1.05% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +0.76 | -22.38 | -24.02 | +26.62 | +9.79 | +0.3 | +5.61 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
National Health Investors, Inc. is a real estate investment trust. The Company specializes in sales, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment consists of real estate investments, leases, and mortgage and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. It has approximately 193 healthcare real estate properties located in 33 states and leased primarily pursuant to triple-net leases to 27 tenants. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. This segment has over 15 properties located in eight states with a combined 1,732 units.
Directors
- W. Andrew Adams NEC (75)
- D. Eric Mendelsohn PRE (59)
- John Spaid CFO (61)
- David Travis CAO (46)
- Kevin Pascoe CIN (41)
- Kristin Gaines OTH (49)
- Robert Adams IND (74)
- James Jobe IND (59)
- Robert McCabe IND (71)
- Charlotte Swafford IND (73)
- Robert Webb IND (76)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 24th, 1991
- Public Since
- July 24th, 1991
- No. of Shareholders
- 59,262
- No. of Employees
- 25
- Sector
- Residential & Commercial REITs
- Industry
- Financials
- Exchange
- New York Stock Exchange
- Shares in Issue
- 46,693,091
- Address
- 222 Robert Rose Dr, MURFREESBORO, 37129
- Web
- https://www.nhireit.com/
- Phone
- +1 6158909100
- Auditors
- BDO USA, LLP
Upcoming Events for NHI
Q1 2025 National Health Investors Inc Earnings Call
National Health Investors Inc Annual Shareholders Meeting
National Health Investors Inc Annual Shareholders Meeting
Q2 2025 National Health Investors Inc Earnings Release
Similar to NHI
Acadia Realty Trust
New York Stock Exchange
Acres Commercial Realty
New York Stock Exchange
AG Mortgage Investment Trust
New York Stock Exchange
Agree Realty
New York Stock Exchange
Alexander & Baldwin (Hawaii)
New York Stock Exchange
FAQ
What is the National Health Investors share price?
As of Today at 22:12 UTC, shares in National Health Investors are trading at $75.16. This share price information is delayed by 15 minutes.
How has the National Health Investors share price performed this year?
Shares in National Health Investors last closed at $75.16 and the price had moved by +20.04% over the past 365 days. In terms of relative price strength the National Health Investors share price has outperformed the S&P500 Index by +10.81% over the past year.
What are the analyst and broker recommendations for National Health Investors?
The overall consensus recommendation for National Health Investors is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the National Health Investors dividend yield?
The National Health Investors dividend yield is 4.79% based on the trailing twelve month period.
Does National Health Investors pay a dividend?
Last year, National Health Investors paid a total dividend of $3.60, and it currently has a trailing dividend yield of 4.79%.Looking ahead, the next dividend pay date is 2025-05-02.
When does National Health Investors next pay dividends?
We do not have data on when National Health Investors is to next pay dividends. The historic dividend yield on National Health Investors shares is currently 4.79%.
How do I buy National Health Investors shares?
To buy shares in National Health Investors you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of National Health Investors?
As of the previous close price of $75.16, shares in National Health Investors had a market capitalisation of $3.51bn.
Where are National Health Investors shares listed?
Here are the trading details for National Health Investors:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: NHI
What kind of share is National Health Investors?
Based on an overall assessment of its quality, value and momentum National Health Investors is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a National Health Investors share price forecast for 2025?
The analyst consensus target price for shares in National Health Investors is $80.86. That is 7.58% above the last closing price of $75.16.
Analysts covering National Health Investors currently have a consensus Earnings Per Share (EPS) forecast of $3.10 for the next financial year.
Find out moreWhat is the trend in the National Health Investors share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like National Health Investors. Over the past six months, its share price has outperformed the S&P500 Index by +5.39%.
As of the last closing price of $75.16, shares in National Health Investors were trading +0.59% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the National Health Investors PE Ratio?
The National Health Investors PE ratio based on its reported earnings over the past 12 months is 23.79. The shares last closed at $75.16.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of National Health Investors?
National Health Investors' management team is headed by:
- W. Andrew Adams - NEC
- D. Eric Mendelsohn - PRE
- John Spaid - CFO
- David Travis - CAO
- Kevin Pascoe - CIN
- Kristin Gaines - OTH
- Robert Adams - IND
- James Jobe - IND
- Robert McCabe - IND
- Charlotte Swafford - IND
- Robert Webb - IND